May 14, 2013, 06.10 PM | Source: CNBC-TV18

Hold Dr Reddys Laboratories: Prakash Diwan

One can hold Dr Reddys Laboratories, says Prakash Diwan, Chief Portfolio Strategist of Prakash Diwan's Wealth Circle, ECR.

Prakash Diwan

Director, Altamount Capital Management

Expertise : Equity - Fundamental

More about the Expert...

Prakash Diwan, Chief Portfolio Strategist, Prakash Diwan's Wealth Circle, ECR told CNBC-TV18, "This is the beginning of a very strong momentum in Dr Reddys Laboratories . If one looks at the changes in the management which they have announced recently are people who actually hold a lot of promising potential in terms of taking the company forward. The company’s pipeline also is significantly stronger."

He further added, "The best point is the valuations, I don’t think valuations are stretched as compared to Sun Pharma or a Cipla or a Lupin relatively. I think the investor should hold on. Wait for another 20-25 percent of an upside in the next 9 to 12 months if the investor is patient enough."

Set email alert for


video of the day

Domestic stories attractive; prefer KNR over L&T: HDFC Sec

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.